692. In Vitro Antibacterial Activity of Cefiderocol Against a Multi-national Collection of Carbapenem-Nonsusceptible Gram-Negative Bacteria From Respiratory Infections: SIDERO-WT-2014–2017

BACKGROUND: Cefiderocol (CFDC) is a new siderophore cephalosporin with potent in vitro activity against a broad range of Gram-negative (GN) pathogens, including carbapenem-nonsusceptible (Carb-NS) strains. We evaluated the in vitro activity of CFDC and comparator agents against recent clinical Carb-...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Sonia N, Nguyen, Sean T, Soriano, Melinda M, Hayes, Jennifer M, Hackel, Meredith M, Sahm, Daniel F, Tillotson, Glenn S, Echols, Roger, Tsuji, Masakatsu, Yamano, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810989/
http://dx.doi.org/10.1093/ofid/ofz360.760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810989/
http://dx.doi.org/10.1093/ofid/ofz360.760

Ejemplares similares